Therapy News and Research

RSS

Electric skin patch offers drug-free solution to bacterial infections

Using a few zaps of electricity to the skin, researchers can stop bacterial infections without using any drugs. For the first time, researchers designed a skin patch that uses imperceptible electric currents to control microbes.

24 Oct 2024

Study highlights dangers of burning incense for allergy and asthma patients

In many cultures, it is common to burn incense for religious and cultural practices, including meditations, celebrations and spiritual and ancestral worship.

24 Oct 2024

UPM Biomedicals launches FibGel™ the world's first injectable nanocellulose hydrogel for medical devices

UPM Biomedicals, the forerunner in producing high quality nanofibrillar cellulose for medical and life science applications, today announces the launch of FibGel™—a natural injectable hydrogel for permanent implantable medical devices.

From UPM Biomedicals 24 Oct 2024

Secure computing enables collaborative cancer research

The research project Federated Secure Computing, funded by the Stifterverband, handles cancer patient data analysis in the European health data space across national borders without sharing any actual data, utilizing the modern cryptographic method - secure multiparty computation. The European research team includes scientists from LMU Munich, Germany, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy, and cryptography experts from Cybernetica, Estonia.

24 Oct 2024

How dancing can supercharge your health after 55: Discover why ballroom beats the gym!

Dance programs improve older adults' physical and mental well-being, with ballroom and folk dance showing the most consistent benefits. More inclusive, theory-driven studies are needed to optimize outcomes.

24 Oct 2024

New antibody platform targets evolving viruses

Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies.

23 Oct 2024

myeloMATCH program opens enrollment for acute myeloid leukemia and MDS

Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to myeloMATCH, a unique portfolio of clinical trials to test precision medicine treatments for adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

23 Oct 2024

Study reveals innovative treatment for narcolepsy-related nightmares

A new Northwestern Medicine study has demonstrated a new way to treat narcolepsy-related nightmares.

23 Oct 2024

NIH launches precision medicine trial to test new treatments for myeloid cancers

The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of people with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

23 Oct 2024

Multigene RNA signature enhances treatment strategies for triple negative breast cancer

Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to improve disease-free survival, finds a clinical trial published by The BMJ today.

23 Oct 2024

Groundbreaking findings on TET2 pathway open doors for targeted blood cancer treatments

Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2).

23 Oct 2024

Human midbrain organoids: A promising tool in the fight against Parkinson's disease

Advancements in organoid technology are crucial for Parkinson's disease research, providing human-relevant models for studying disease and testing therapies.

23 Oct 2024

Advancements in antibody-drug conjugates transform cancer therapy

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of cytotoxic drugs.

22 Oct 2024

Tissue stiffening linked to disease progression in HER2-negative breast cancer

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can directly cause disease progression and metastasis, leading to detrimental outcomes for patients.

22 Oct 2024

Structural biology reveals secrets of DEV phage infection

The viruses that infect bacteria are the most abundant biological entities on the planet. For example, a recent simple study of 92 showerheads and 36 toothbrushes from American bathrooms found more than 600 types of bacterial viruses, commonly called bacteriophages or phages.

22 Oct 2024

Therapy News and Research

Electric skin patch offers drug-free solution to bacterial infections

Study highlights dangers of burning incense for allergy and asthma patients

UPM Biomedicals launches FibGel™ the world's first injectable nanocellulose hydrogel for medical devices

Secure computing enables collaborative cancer research

How dancing can supercharge your health after 55: Discover why ballroom beats the gym!

New antibody platform targets evolving viruses

myeloMATCH program opens enrollment for acute myeloid leukemia and MDS

Study reveals innovative treatment for narcolepsy-related nightmares

NIH launches precision medicine trial to test new treatments for myeloid cancers

Multigene RNA signature enhances treatment strategies for triple negative breast cancer

Groundbreaking findings on TET2 pathway open doors for targeted blood cancer treatments

Human midbrain organoids: A promising tool in the fight against Parkinson's disease

Advancements in antibody-drug conjugates transform cancer therapy

Tissue stiffening linked to disease progression in HER2-negative breast cancer

Structural biology reveals secrets of DEV phage infection

Cutting off cancer cells' access to fats may enhance cancer therapy

Brain-stimulation therapy at home reduces major depression symptoms

New antibody targets cancer-causing HER2 mutations

Telemedicine and low-carb diet slashes diabetes meds and drives lasting remission

New CAR T cells offer controlled treatment for solid tumors

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News